MicroPort CardioFlow Medtech Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Jeffrey R Lindstrom
Chief executive officer
CN¥4.0m
Total compensation
| CEO salary percentage | 59.8% |
| CEO tenure | 1.3yrs |
| CEO ownership | n/a |
| Management average tenure | 4.2yrs |
| Board average tenure | 3.9yrs |
Recent management updates
Recent updates
MicroPort CardioFlow Medtech Corporation (HKG:2160) Stocks Shoot Up 34% But Its P/S Still Looks Reasonable
Sep 27
After Leaping 34% MicroPort CardioFlow Medtech Corporation (HKG:2160) Shares Are Not Flying Under The Radar
Sep 27Are Investors Undervaluing MicroPort CardioFlow Medtech Corporation (HKG:2160) By 43%?
Aug 07Some MicroPort CardioFlow Medtech Corporation (HKG:2160) Shareholders Look For Exit As Shares Take 26% Pounding
Jun 19MicroPort CardioFlow Medtech (HKG:2160) Is In A Good Position To Deliver On Growth Plans
May 29MicroPort CardioFlow Medtech Corporation (HKG:2160) Shares May Have Slumped 29% But Getting In Cheap Is Still Unlikely
Apr 05We Think MicroPort CardioFlow Medtech (HKG:2160) Can Afford To Drive Business Growth
Feb 23An Intrinsic Calculation For MicroPort CardioFlow Medtech Corporation (HKG:2160) Suggests It's 37% Undervalued
Jan 18Companies Like MicroPort CardioFlow Medtech (HKG:2160) Are In A Position To Invest In Growth
Oct 04Not Many Are Piling Into MicroPort CardioFlow Medtech Corporation (HKG:2160) Stock Yet As It Plummets 27%
May 31We Think MicroPort CardioFlow Medtech (HKG:2160) Can Afford To Drive Business Growth
May 23The MicroPort CardioFlow Medtech Corporation (HKG:2160) Analysts Have Been Trimming Their Sales Forecasts
Apr 06MicroPort CardioFlow Medtech (HKG:2160) Is In A Good Position To Deliver On Growth Plans
Feb 08We Think MicroPort CardioFlow Medtech (HKG:2160) Can Afford To Drive Business Growth
Oct 18We're Not Very Worried About MicroPort CardioFlow Medtech's (HKG:2160) Cash Burn Rate
Jun 30Analysts Just Made A Major Revision To Their MicroPort CardioFlow Medtech Corporation (HKG:2160) Revenue Forecasts
Apr 04MicroPort CardioFlow Medtech Corporation (HKG:2160) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
Apr 03An Intrinsic Calculation For MicroPort CardioFlow Medtech Corporation (HKG:2160) Suggests It's 49% Undervalued
Jan 21Are Investors Undervaluing MicroPort CardioFlow Medtech Corporation (HKG:2160) By 24%?
Sep 05We're Not Worried About MicroPort CardioFlow Medtech's (HKG:2160) Cash Burn
Jun 07Market Sentiment Around Loss-Making MicroPort CardioFlow Medtech Corporation (HKG:2160)
May 03CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -CN¥349m |
| Mar 31 2024 | n/a | n/a | -CN¥410m |
| Dec 31 2023 | CN¥4m | CN¥2m | -CN¥472m |
Compensation vs Market: Jeffrey R's total compensation ($USD548.79K) is above average for companies of similar size in the Hong Kong market ($USD346.63K).
Compensation vs Earnings: Insufficient data to compare Jeffrey R's compensation with company performance.
CEO
Jeffrey R Lindstrom (57 yo)
1.3yrs
Tenure
CN¥4,004,000
Compensation
Mr. Jeffrey R Lindstrom is President, Executive Director & General Manager of MicroPort CardioFlow Medtech Corporation from August 29, 2023. He served as senior director of engineering in Edwards Lifescien...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 1.3yrs | CN¥4.00m | no data | |
| Executive Director & First VP of Total Solutions | 2.6yrs | CN¥3.91m | 0.058% HK$ 944.8k | |
| VP & Executive Director | 4.3yrs | CN¥2.70m | 0.042% HK$ 678.3k | |
| Joint Company Secretary | 4.2yrs | no data | no data | |
| Joint Company Secretary | 4.2yrs | no data | no data |
4.2yrs
Average Tenure
43yo
Average Age
Experienced Management: 2160's management team is considered experienced (4.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 1.3yrs | CN¥4.00m | no data | |
| Executive Director & First VP of Total Solutions | 2.6yrs | CN¥3.91m | 0.058% HK$ 944.8k | |
| VP & Executive Director | 4.3yrs | CN¥2.70m | 0.042% HK$ 678.3k | |
| Independent Non-Executive Director | 3.9yrs | CN¥254.00k | no data | |
| Non-Executive Director | 5.3yrs | no data | no data | |
| Non-Executive Chairman of the Board | 4.3yrs | CN¥3.16m | 0.031% HK$ 497.7k | |
| Non-Executive Director | 5.3yrs | no data | no data | |
| Independent Non-Executive Director | 3.9yrs | CN¥254.00k | no data | |
| Independent Non-Executive Director | 3.3yrs | CN¥254.00k | 0.0012% HK$ 20.0k |
3.9yrs
Average Tenure
47yo
Average Age
Experienced Board: 2160's board of directors are considered experienced (3.9 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 10:23 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
MicroPort CardioFlow Medtech Corporation is covered by 9 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yang Luo | BOCI Research Ltd. |
| Sharon Shi | BOCI Research Ltd. |
| Harry He | CGS International |